Administration
Administration
批准号:
10631867
负责人:
GEORGE M SHAW
金额:
$12.17万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-03-07 至 2027-03-31
关键词:
AccountingAntibodiesAwardCommunicationDedicationsEnsureFundingGoalsGuidelinesHIV-1Human ResourcesIACUCInformation TechnologyInfrastructureInstitutionLeadLeadershipMeasuresMolecularMonitorOccupational activity of managing financesPennsylvaniaPolysaccharidesReportingResearchResourcesScienceUniversitiesVaccine DesignWorkdata sharingexperiencemeetingsprogramssimian human immunodeficiency virus
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
Scientific and administrative leadership and effective program project management of the HIVRAD is the goal of
Core A. The core will oversee scientific progress relative to project aims and milestones and lead scientific efforts
in conjunction with the Executive Committee and Scientific Advisory Board. It will coordinate financial
management, research program management, regulatory compliance and reporting functions. In addition to
coordinating these activities, the Administrative Core will be responsible for promoting and documenting all
aspects of scientific, IACUC and financial regulatory compliance at Penn and subcontracting institutions. Staff
on this core are located within the administrative offices of Dr. Shaw, thus taking advantage of a highly
experienced and integrated management team. The University of Pennsylvania provides infrastructure support
for administration, information technology, IACUC oversight and compliance, and human resources, and also
provides dedicated pre- and post-award units to facilitate administrative and fiduciary compliance. Penn will
provide this support for the HIVRAD. A highly functional administrative core will contribute to and facilitate the
successful advancement of the proposed science. Specific aims of Core A are to: (i) provide scientific and
administrative leadership and program coordination; (ii) ensure timely financial accounting and reporting; (iii)
ensure regulatory compliance with all institutional and federal research guidelines; and (iv) develop and
implement an HIVRAD communications and data sharing plan.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reverse Vaccinology in SHIV Infected Macaques as a Molecular Guide for HIV-1 Vaccine Design
-
批准号:10577775
-
项目类别:
-
资助金额:$80.43万
-
财政年份:2021
-
负责人:GEORGE M SHAW
-
依托单位:
HIV-1 Q23.17 Env: Engineering a novel immunogen to elicit broadly neutralizing antibodies
-
批准号:10624301
-
项目类别:
-
资助金额:$116.18万
-
财政年份:2021
-
负责人:GEORGE M SHAW
-
依托单位:
Reverse Vaccinology in SHIV Infected Macaques as a Molecular Guide for HIV-1 Vaccine Design
-
批准号:10370383
-
项目类别:
-
资助金额:$80.43万
-
财政年份:2021
-
负责人:GEORGE M SHAW
-
依托单位:
HIV-1 Q23.17 Env: Engineering a novel immunogen to elicit broadly neutralizing antibodies
-
批准号:10437032
-
项目类别:
-
资助金额:$80.43万
-
财政年份:2021
-
负责人:GEORGE M SHAW
-
依托单位:
HIV-1 Q23.17 Env: Engineering a novel immunogen to elicit broadly neutralizing antibodies
-
批准号:10326691
-
项目类别:
-
资助金额:$80.33万
-
财政年份:2021
-
负责人:GEORGE M SHAW
-
依托单位:
Reverse Vaccinology in SHIV Infected Macaques as a Molecular Guide for HIV-1 Vaccine Design
-
批准号:10224528
-
项目类别:
-
资助金额:$80.35万
-
财政年份:2021
-
负责人:GEORGE M SHAW
-
依托单位:
SHIV/HIV Env-Antibody Coevolution as a Guide to Iterative Vaccine Design
-
批准号:9316783
-
项目类别:
-
资助金额:$334.23万
-
财政年份:2017
-
负责人:GEORGE M SHAW
-
依托单位:
Env evolution in humans and RMs
-
批准号:10117175
-
项目类别:
-
资助金额:$109.37万
-
财政年份:2017
-
负责人:GEORGE M SHAW
-
依托单位:
Env-Ab coevolution in SHIV infected RMs leading to V3 glycan bNAbs
-
批准号:10370983
-
项目类别:
-
资助金额:$140.56万
-
财政年份:2017
-
负责人:GEORGE M SHAW
-
依托单位:
SHIV/HIV Env-Antibody Coevolution as a Guide to Iterative Vaccine Design
-
批准号:10117167
-
项目类别:
-
资助金额:$321.87万
-
财政年份:2017
-
负责人:GEORGE M SHAW
-
依托单位:
Administrative Core
-
批准号:10117174
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2017
-
负责人:GEORGE M SHAW
-
依托单位:
SHIV Env-antibody coevolution as a molecular guide to HIV-1 V3 glycan targeted vaccine design
-
批准号:10370979
-
项目类别:
-
资助金额:$417.88万
-
财政年份:2017
-
负责人:GEORGE M SHAW
-
依托单位:
SHIV Env-antibody coevolution as a molecular guide to HIV-1 V3 glycan targeted vaccine design
-
批准号:10631866
-
项目类别:
-
资助金额:$410.48万
-
财政年份:2017
-
负责人:GEORGE M SHAW
-
依托单位:
Env-Ab coevolution in SHIV infected RMs leading to V3 glycan bNAbs
-
批准号:10631887
-
项目类别:
-
资助金额:$140.56万
-
财政年份:2017
-
负责人:GEORGE M SHAW
-
依托单位:
bNAb induction by antigenically diverse V1V2 lineage specific SHIVs and SOSIPs
-
批准号:9975687
-
项目类别:
-
资助金额:$79.69万
-
财政年份:2017
-
负责人:GEORGE M SHAW
-
依托单位:
Administration
-
批准号:10370980
-
项目类别:
-
资助金额:$12.17万
-
财政年份:2017
-
负责人:GEORGE M SHAW
-
依托单位:
Targeting 5' leader-encoded defective ribosomal products for HIV T cell vaccines
-
批准号:9220707
-
项目类别:
-
资助金额:$71.62万
-
财政年份:2016
-
负责人:GEORGE M SHAW
-
依托单位:
Molecular analysis of the mucosal SIVsmm transmission bottleneck
-
批准号:8497587
-
项目类别:
-
资助金额:$65.71万
-
财政年份:2013
-
负责人:GEORGE M SHAW
-
依托单位:
Administration
-
批准号:8497589
-
项目类别:
-
资助金额:$11.79万
-
财政年份:2013
-
负责人:GEORGE M SHAW
-
依托单位:
Penile transmission and neutralization of pathogenic SIVsmm
-
批准号:8115642
-
项目类别:
-
资助金额:$9.5万
-
财政年份:2011
-
负责人:GEORGE M SHAW
-
依托单位:
海外基金